Dermira (DERM) Tops Q3 EPS by $1.15

Dermira (NASDAQ: DERM) reported Q3 EPS of $0.99, $1.15 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $34.54 million versus the consensus estimate of $16.9 million.

For earnings history and earnings-related data on Dermira (DERM) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
• UBS Reiterates Buy Rating on General Motors (GM) as Defense Opportunity in Focus